BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11751505)

  • 1. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients.
    Molnar B; Ladanyi A; Tanko L; Sréter L; Tulassay Z
    Clin Cancer Res; 2001 Dec; 7(12):4080-5. PubMed ID: 11751505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
    Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
    Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
    Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
    Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis.
    Koch M; Kienle P; Logan E; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schmidt J; Herfarth C; Weitz J
    Ann Surg Oncol; 2007 Feb; 14(2):810-7. PubMed ID: 17103077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.
    Witzig TE; Bossy B; Kimlinger T; Roche PC; Ingle JN; Grant C; Donohue J; Suman VJ; Harrington D; Torre-Bueno J; Bauer KD
    Clin Cancer Res; 2002 May; 8(5):1085-91. PubMed ID: 12006523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.